Filing Details
- Accession Number:
- 0001140361-24-017566
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-03 16:01:48
- Reporting Period:
- 2024-04-01
- Accepted Time:
- 2024-04-03 16:01:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124105 | Gyre Therapeutics Inc. | GYRE | Pharmaceutical Preparations (2834) | 562020050 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206872 | Nassim Usman | C/O Gyre Therapeutics, Inc. 12770 High Bluff Drive, Suite 150 San Diego CA 92130 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-01 | 20,000 | $6.93 | 21,636 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-01 | 20,000 | $16.15 | 1,636 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-01 | 20,000 | $0.00 | 20,000 | $6.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 301,652 | 2033-10-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 563 | Indirect | By The Usman Family Trust |
| Common Stock | 77 | Indirect | By Nassim Usman IRA |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $15.80 to $17.15. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- This option is vested in full.
Billionaire Hedge Funds
